Bifidobacterium breve MCC1274
Bifidobacterium breve MCC1274 has an emerging body of research focused primarily on brain-gut interactions and cognitive health. A 24-week randomized, double-blind, placebo-controlled trial in older adults with suspected mild cognitive impairment examined cognitive function scores and brain atrophy measures as outcomes. Animal studies using APP knock-in mouse models of Alzheimer's disease have examined this strain in relation to amyloid-beta production and microglial activation, including possible metabolite pathways involving tryptophan derivatives and oxidative stress. In vitro work has explored metabolite profiles when the strain is co-cultured with intestinal epithelial cells. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 23 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 2 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
25 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 41935066 →Dietary silver nanoparticle supplementation induces Alzheimer-like lesions through Bifidobacterium deficiency-dominated gut microbiota dysbiosis and neuroinflammation· npj Science of Food · 2026
-
[2]
PMID 33814441 →Association of Plasma Hemoglobin A1c with Improvement of Cognitive Functions by Probiotic Bifidobacterium breve Supplementation in Healthy Adults with Mild Cognitive Impairment· Journal of Alzheimer s Disease · 2021
-
[3]
PMID 32623402 →Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial· Journal of Alzheimer s Disease · 2020